The Japan 3D bioprinting market size was valued at USD 82.9 Million in 2024, and it is expected to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% from 2025 to 2033.
To get more information on this market, Request Sample
Japan's aging demographic is inflating the requirement for advanced healthcare solutions, particularly in areas like organ replacement, tissue regeneration, and personalized therapies. For instance, the elderly population aged 65 and above in Japan surpassed 30 million in 2024. Bioprinting provides innovative solutions for age-related health issues, thereby fueling its growth within the pharmaceutical sector. Additionally, Japan’s 3D bioprinting market is supported by the escalating demand for advanced manufacturing technologies in the healthcare and F&B industries.
Innovations in bioprinting techniques are enabling the development of customized tissues, organ models, and even edible products like cultured meat. They aid in enhancing precision, sustainability, and personalization in production processes. In March 2024, Osaka University, Shimadzu, Itoham Yonekyu, Toppan, and SIGMAXYZ formed a consortium to advance 3D bioprinting for edible cultured meat. The group focuses on developing bioprinting technology, establishing a production-to-logistics value chain, and collaborating with government and industry to shape legislation. They plan to showcase their efforts at the 2025 World Expo in Osaka.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include Kanto region, Kansai/Kinki region, Central/ Chubu region, Kyushu-Okinawa region, Tohoku region, Chugoku region, Hokkaido region, and Shikoku region. The escalating need for cancer therapeutics, along with the elevating adoption of regenerative medicines, is expanding the market.
In the Kanto region, Cyfuse Biomedical, based in Tokyo, created the Kenzan method, a scaffold-free 3D bioprinting technology that allows for exact tissue creation. This technique was used to evaluate drugs on liver tissue models. Also, the University of Tokyo collaborates on vascularized organ bioprinting. Besides this, various companies across this region, like Riken and Toppan invest in biomaterials, further driving the market expansion.
Kyoto University in the Kansai/Kinki region has 3D-printed nerve conduits, proving their potential to regenerate peripheral nerves in animal models. At the same time, Osaka University has enhanced cardiac repair by generating functional heart tissue with bioprinting technology. Besides this, the Kobe biomedical cluster is also promoting drug screening advancements through bioprinting applications.
Nagoya University in the Central/Chugoku region is working on 3D bioprinting to improve bone regeneration, developing scaffolds that support orthopedic treatments. In line with this, at Toyohashi University of Technology, researchers are exploring cartilage bioprinting to enhance joint repair. Besides this, in Aichi, various biotech companies are investing in dental bioprinting, aiming to create customized implants.
Kyushu University is making significant progress in liver tissue bioprinting for drug testing and regenerative medicine, which is driving the market expansion. Besides this, Okinawa Institute of Science and Technology specializes in hydrogels for soft tissue engineering. Moreover, various companies across this region use 3D bioprinting and organ-on-a-chip technology to enhance pharmaceutical testing.
Various key universities across the Tohoku region are focusing on neural tissue bioprinting to treat neurodegenerative illnesses. For instance, Fukushima Medical University creates 3D-printed spinal cord grafts for paralysis rehabilitation. Besides this, Akita's biotech sector is investigating bio-inks that enhance neuron regeneration, further bolstering the market.
Researchers across the Chugoku region are developing bio-printed skin grafts to improve treatments for burns and wounds, aiming to enhance healing. Scientists at Okayama University are developing 3D-printed corneal tissue to help patients with eye injuries or disorders regain their vision. At the same time, biotech companies in the region are developing bio-ink creations that can help in epithelium regeneration.
Hokkaido University is focusing on the advancement of vascularized tissue bioprinting to improve graft survival, which is driving the market expansion in the Hokkaido region. The region’s strength in cryopreservation supports progress in bio fabrication. Besides this, various companies across the region are developing bio-printed blood vessels for organ transplants.
Shikoku region, known for traditional herbal medicine, is exploring 3D bioprinting for personalized Kampo-based treatments. Various universities in Tokushima University are developing bio-print hydrogel-infused herbal scaffolds for controlled drug release. Also, various pharmaceutical companies in Kagawa are integrating bioprinting with plant-derived bioactive compounds for regenerative applications.
Key players across the country are investing in introducing novel methods, thereby elevating the market. In July 2024, scientists at the University of Tokyo developed a method to attach living skin to robots by using 3D printing. Furthermore, in January 2025, Roland DG unveiled a ceramic 3D printing technology at TCT Japan with complex structures.
Report Features | Details |
---|---|
Market Size in 2024 | USD 82.9 Million |
Market Forecast in 2033 | USD 316.7 Million |
Market Growth Rate 2025-2033 | 16.1% |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Components Covered |
|
Applications Covered |
|
End Users Covered | Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies |
Regions Covered | Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |